Amphastar Pharmaceuticals, Inc. — Director's Dealing 2014

Jun 25, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2014-06-24

Reporting Person: Shandell Jason B. (Director, President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18102	Direct
Common Stock	666	Direct
Common Stock	4095	Direct
Common Stock	5253	Direct
Common Stock	36121	Direct
Common Stock	63195	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$33.49	2018-05-09	Common Stock (8000)		Direct
Stock Option (Right to Buy)	$33.49	2018-07-07	Common Stock (4000)		Direct
Stock Option (Right to Buy)	$35.32	2018-08-28	Common Stock (5000)		Direct
Stock Option (Right to Buy)	$20.26	2019-08-02	Common Stock (7500)		Direct
Stock Option (Right to Buy)	$11.79	2020-09-28	Common Stock (6000)		Direct
Stock Option (Right to Buy)	$15.23	2021-10-03	Common Stock (7519)		Direct
Stock Option (Right to Buy)	$10.46	2022-07-13	Common Stock (56996)		Direct
Stock Option (Right to Buy)	$10.48	2022-09-28	Common Stock (16630)		Direct
Stock Option (Right to Buy)	$10.93	2023-07-05	Common Stock (151988)		Direct
Stock Option (Right to Buy)	$14.4	2024-03-27	Common Stock (91345)		Direct

Footnotes

F1: Includes 6,000 shares held by the Reporting Person and his spouse, Carolina Shandell, as joint tenants with rights of survivorship.

F2: This represents the remaining amount of deferred stock units that were granted on 8/2/2009. The original amount was 3,332. This vests over 5 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.

F3: This represents the remaining amount of deferred stock units that were granted on 9/28/2010. The original amount was 10,239. This vests over 5 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.

F4: This represents the remaining amount of deferred stock units that were granted on 10/3/2011. The original amount was 10,506. This vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.

F5: This represents deferred stock units that were granted on 7/5/2013 and vest over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.

F6: This represents deferred stock units that were granted on 3/27/2014 and vest over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.

F7: This option is fully vested and exercisable.

F8: This option was granted on 8/2/2009 and vests over 5 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued (i) employment with or service to the Issuer or subsidiary thereof and (ii) service on the Board of Directors of the Issuer, in each case through the applicable vesting date.

F9: This option was granted on 9/28/2010 and vests over 5 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued (i) employment with or service to the Issuer or subsidiary thereof and (ii) service on the Board of Directors of the Issuer, in each case through the applicable vesting date.

F10: This option was granted on 10/3/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued (i) employment with or service to the Issuer or subsidiary thereof and (ii) service on the Board of Directors of the Issuer, in each case through the applicable vesting date.

F11: This option was granted on 7/13/2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued (i) employment with or service to the Issuer or subsidiary thereof and (ii) service on the Board of Directors of the Issuer, in each case through the applicable vesting date.

F12: This option was granted on 9/28/2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued (i) employment with or service to the Issuer or subsidiary thereof and (ii) service on the Board of Directors of the Issuer, in each case through the applicable vesting date.

F13: This option was granted on 7/5/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued (i) employment with or service to the Issuer or subsidiary thereof and (ii) service on the Board of Directors of the Issuer, in each case through the applicable vesting date.

F14: This option was granted on 3/27/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued (i) employment with or service to the Issuer or subsidiary thereof and (ii) service on the Board of Directors of the Issuer, in each case through the applicable vesting date.